Proposed Data Collection Submitted for Public Comment and Recommendations, 95792-95793 [2024-28322]

Download as PDF 95792 Federal Register / Vol. 89, No. 232 / Tuesday, December 3, 2024 / Notices Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–28320 Filed 12–2–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–25–1363; Docket No. CDC–2024– 0097] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies to take this opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Research Data Center (RDC) Proposal for Access to Confidential Data for the National Center for Health Statistics (NCHS). This data collection is used to assess researcher’s request for access to confidential NCHS data for their research projects. DATES: Written comments must be received on or before February 3, 2025. ADDRESSES: You may submit comments, identified by Docket No. CDC–2024– 0097 by any of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to www.regulations.gov, including any lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:09 Dec 02, 2024 Jkt 265001 personal information provided. For access to the docket to read background documents or comments received, go to www.regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Research Data Center (RDC) Proposal for Access to Confidential Data for the National Center for Health Statistics (OMB Control No. 0920–1363, Exp. 4/ 30/2025)—Extension—National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Background and Brief Description Section 306(b)(4) of the Public Health Service (PHS) Act (42 U.S.C. 242k(b)(4)), as amended, authorizes the Secretary of Health and Human Services (DHHS), acting through NCHS, to receive requests for providing data and statistics to the public. NCHS receives requests for confidential data from the public through the Research Data Center (RDC) Proposal for Access to Confidential Data. This is a request for an Extension without change from OMB to collect information via the RDC proposal over the next three years at an overall burden rate of 990 hours. As part of a comprehensive data dissemination program, the Research Data Center (RDC), National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention, requires prospective researchers who need access to confidential data to complete a research proposal. Researchers self-select whether they need access to confidential data to answer their research questions. The RDC requires the researcher to complete a research proposal so NCHS understands the research proposed, whether confidential data are available to address the research questions, how the confidential data will be used and what data outputs the researcher needs to satisfy their project. The completed proposal is sent to NCHS for adjudication on whether the proposed research is possible. To capture the information needed to adjudicate researchers’ need for access to confidential NCHS data, this request allows for both respondents and time per response for a total estimated annual burden total of 330 hours (990 hours for a three-year clearance period). There is no cost to respondents other than their time to complete the proposal. E:\FR\FM\03DEN1.SGM 03DEN1 95793 Federal Register / Vol. 89, No. 232 / Tuesday, December 3, 2024 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Avg. burden per response (in hrs.) Total burden (in hrs.) Form name Researcher ........................................ Research Data Center proposal ...... 110 1 3 330 Total ........................................... ........................................................... 330 ........................ ........................ ........................ Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–28322 Filed 12–2–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2024–0100] Draft CDC’s Recommendations for HIV Screening in Clinical Settings Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention in the Department of Health and Human Services announces the opening of a docket to obtain comment on the draft Recommendations for HIV Screening in Clinical Settings, that update portions of CDC’s ‘‘Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings,’’ published in 2006. DATES: Written comments must be received on or before January 2, 2025. ADDRESSES: You may submit comments, identified by Docket No. CDC–2024– 0100 by either of the methods listed below. Do not submit comments by email. CDC does not accept comments by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop U.S. 8–6, Atlanta, GA 30329–4027. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to https://regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 Number of responses per respondent Number of respondents Type of respondents VerDate Sep<11>2014 17:09 Dec 02, 2024 Jkt 265001 FOR FURTHER INFORMATION CONTACT: Cecily Campbell, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop U.S. 8–6, Atlanta, GA 30329– 4027, Email: nchhstppolicy@cdc.gov. Office phone: 404–639–0485. SUPPLEMENTARY INFORMATION: CDC is requesting public comment on the draft ‘‘Recommendations for HIV Screening in Clinical Settings,’’ which is available on regulations.gov in Docket CDC– 2024–0100. These recommendations modify the ages for HIV screening including eliminating an upper age limit, encourage providers to use clinical decision support tools such as automated HIV test laboratory orders to implement HIV screening, provide considerations for healthcare populations on which to conduct HIV screening, recommend anyone who requests a test should be tested, and emphasize the use of a general consent process as used for other routine tests. CDC describes the methods and supporting evidence in the recommendations. The recommendations’ objectives are to diagnose and link patients with undiagnosed infection to clinical care; relink persons with previously diagnosed HIV to clinical care; diagnose HIV infection earlier; and reduce HIV transmission in the United States. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. In addition, CDC invites comments specifically on the following questions proposed in this document: • Does the evidence presented support the proposed recommendations for HIV screening in clinical settings, including the benefits and harms of HIV screening? If not, please state the reason why and, if available, provide additional evidence for consideration. • Are CDC’s proposed recommendations for HIV screening in clinical settings clearly written? If not, what changes do you propose to make it clearer? • If implemented as currently drafted, do you believe these recommendations would improve HIV screening in PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 clinical settings, improve diagnoses and linking patients with undiagnosed infection to clinical care; relinking persons with previously diagnosed HIV to clinical care; diagnosing HIV infection earlier; and reducing HIV transmission in the United States? If not, please provide an explanation and supporting data or evidence. • How should CDC disseminate the final recommendations to effectively reach end users such as healthcare providers in clinical settings? • After the recommendations are finalized, CDC is planning to publish an implementation guide for healthcare providers to supplement the updated recommendations. What should the implementation guide include? Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. Do not submit comments by email. CDC does not accept comment by email. After the comments received on the draft are considered and addressed, the final recommendations will be published on CDC’s website at https:// www.cdc.gov/hiv/guidelines/ testing.html. The final recommendations will also be posted to docket CDC– 2024–0100 at www.regulations.gov. Background Human immunodeficiency virus (HIV) is a virus that attacks the body’s immune system. The only way a person can know their HIV status is by getting tested (CDC, 2024a). While there is no E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 89, Number 232 (Tuesday, December 3, 2024)]
[Notices]
[Pages 95792-95793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-25-1363; Docket No. CDC-2024-0097]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies to take this opportunity to comment on a continuing 
information collection, as required by the Paperwork Reduction Act of 
1995. This notice invites comment on the Research Data Center (RDC) 
Proposal for Access to Confidential Data for the National Center for 
Health Statistics (NCHS). This data collection is used to assess 
researcher's request for access to confidential NCHS data for their 
research projects.

DATES: Written comments must be received on or before February 3, 2025.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0097 by any of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to www.regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Research Data Center (RDC) Proposal for Access to Confidential Data 
for the National Center for Health Statistics (OMB Control No. 0920-
1363, Exp. 4/30/2025)--Extension--National Center for Health Statistics 
(NCHS), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Section 306(b)(4) of the Public Health Service (PHS) Act (42 U.S.C. 
242k(b)(4)), as amended, authorizes the Secretary of Health and Human 
Services (DHHS), acting through NCHS, to receive requests for providing 
data and statistics to the public. NCHS receives requests for 
confidential data from the public through the Research Data Center 
(RDC) Proposal for Access to Confidential Data. This is a request for 
an Extension without change from OMB to collect information via the RDC 
proposal over the next three years at an overall burden rate of 990 
hours.
    As part of a comprehensive data dissemination program, the Research 
Data Center (RDC), National Center for Health Statistics (NCHS), 
Centers for Disease Control and Prevention, requires prospective 
researchers who need access to confidential data to complete a research 
proposal. Researchers self-select whether they need access to 
confidential data to answer their research questions. The RDC requires 
the researcher to complete a research proposal so NCHS understands the 
research proposed, whether confidential data are available to address 
the research questions, how the confidential data will be used and what 
data outputs the researcher needs to satisfy their project. The 
completed proposal is sent to NCHS for adjudication on whether the 
proposed research is possible.
    To capture the information needed to adjudicate researchers' need 
for access to confidential NCHS data, this request allows for both 
respondents and time per response for a total estimated annual burden 
total of 330 hours (990 hours for a three-year clearance period). There 
is no cost to respondents other than their time to complete the 
proposal.

[[Page 95793]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Researcher....................  Research Data                110               1               3             330
                                 Center proposal.
                               ---------------------------------------------------------------------------------
    Total.....................  ................             330  ..............  ..............  ..............
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-28322 Filed 12-2-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.